Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells

Digestive Diseases and Sciences

Volumn 54, Issue 7, 2009, Pages 1418-1424

  Liu, Hua ^a   Huang, Peixin ^a   Xu, Xuanfu ^a   Liu, Jun ^a   Guo, Chuanyong ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Cyclooxygenase 2 dependent pathway; Cyclooxygenase 2 independent pathway; Gastric carcinoma; RNA interference

Indexed keywords

CELECOXIB; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOOXYGENASE 2; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

BLOTTING, WESTERN; CELL PROLIFERATION; CHEMOPREVENTION; COLONY-FORMING UNITS ASSAY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; GENES, BCL-2; HUMANS; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 67349211750     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0510-9     Document Type: Article

References (35)

1. C Cuccurullo ML Fazia A Mezzetti F Cipollone 2007 COX-2 expression in atherosclerosis: the good, the bad or the ugly? Curr Med Chem 14 1595 1605 10.2174/092986707780830998
2. TG Brock M Peters-Golden 2007 Activation and regulation of cellular eicosanoid biosynthesis ScientificWorld Journal 7 1273 1284 10.1100/tsw.2007.180
3. M Amir HK Agarwal 2005 Role of COX-2 selective inhibitors for prevention and treatment of cancer Pharmazie 60 563 570 (Pubitemid 41153417)
4. MM Bertagnolli 2007 Cox-2 and cancer chemoprevention: picking up the pieces. Recent results in cancer research Fortschr Krebsforschung 174 73 78
5. FH Sarkar S Adsule Y Li S Padhye 2007 Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy Mini Rev Med Chem 7 599 608 10.2174/138955707780859431
6. G Nardone A Rocco 2004 Chemoprevention of gastric cancer: role of COX-2 inhibitors and other agents Dig Dis 22 320 326 10.1159/000083593
7. RE Harris 2007 Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer Subcell Biochem 42 93 126 10.1007/1-4020-5688-5-4
8. LJ Marnett RN DuBois 2002 COX-2: a target for colon cancer prevention Annu Rev Pharmacol Toxicol 42 55 80 10.1146/annurev.pharmtox.42.082301.164620
9. XC Xu 2002 COX-2 inhibitors in cancer treatment and prevention, a recent development Anticancer Drugs 13 127 137 10.1097/00001813-200202000-00003
10. M Farooqui Y Li T Rogers 2007 COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia Br J Cancer 97 1523 1531 10.1038/sj.bjc.6604057
11. VY Shin WK Wu KM Chu 2005 Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer Mol Cancer Res 3 607 615 10.1158/1541-7786.MCR-05-0106
12. MX Da XT Wu J Wang 2008 Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer Arch Med Res 39 92 99 10.1016/j.arcmed.2007.06. 021
13. TJ Maier K Schilling R Schmidt G Geisslinger S Grosch 2004 Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells Biochem Pharmacol 67 1469 1478 10.1016/j.bcp.2003.12.014
14. JH Park KH Kang SH Kim 2005 Expression of Cyclooxygenase-2 and Bcl-2 in human gastric adenomas Korean J Intern Med 20 198 204 (Pubitemid 41723630)
15. XP Liu K Tsushimi M Tsushimi 2001 Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis Cancer Lett 170 183 189 10.1016/S0304-3835(01)00589-4
16. B Belletti MS Nicoloso M Schiappacassi 2005 p27 (kip1) functional regulation in human cancer: a potential target for therapeutic designs Curr Med Chem 12 1589 1605 10.2174/0929867054367149
17. JM Wallace 2002 Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases, and lipoxygenases-as an adjunct in cancer therapy Integr Cancer Ther 1 7 37 (discussion 37) (Pubitemid 37101537)
18. T Kakizoe 2003 Chemoprevention of cancer-focusing on clinical trials Jpn J Clin Oncol 33 421 442 10.1093/jjco/hyg090
19. SS Shin Y Byun KM Lim 2004 In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2, 2-dialkyl-4-phenyl-3(2H)furanone derivatives J Med Chem 47 792 804 10.1021/jm020545z
20. MT Huang ZX Chen B Wei 2007 Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide Acta Pharmacol Sin 28 1842 1850 10.1111/j.1745-7254.2007.00652.x
21. SJ Cho N Kim JS Kim HC Jung IS Song 2007 The anti-cancer effect of COX-2 inhibitors on gastric cancer cells Dig Dis Sci 52 1713 1721 10.1007/s10620-007- 9787-3
22. S Grosch I Tegeder E Niederberger L Brautigam G Geisslinger 2001 COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib FASEB J 15 2742 2744
23. AA Makitie M Chau S Lim 2003 Selective inhibition of cyclooxygenase 2 induces p27kip1 and skp2 in oral squamous cell carcinoma J Otolaryngol 32 226 229 10.2310/7070.2003.41701 (Pubitemid 37314553)
24. BA Narayanan MS Condon MC Bosland NK Narayanan BS Reddy 2003 Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s) Clin Cancer Res 9 3503 3513 (Pubitemid 37082750)
25. WM Liao CL Zhang FB Li BF Zeng YX Zeng 2004 p21WAF1/CIP1 gene DNA sequencing and its expression in human osteosarcoma Chin Med J 117 936 940
26. TA Matsui Y Sowa H Murata 2007 The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line Int J Oncol 31 915 922
27. CM Hui PY Cheung MT Ling 2006 Id-1 promotes proliferation of p53-deficient esophageal cancer cells Int J Cancer 119 508 514 10.1002/ijc.21874
28. T Inadomi M Tan H Suzuki C Shigematsu 1999 Immunohistochemical evaluation of the probability of skin metastasis in gastric cancer Eur J Dermatol 9 214 217 (Pubitemid 29170423)
29. YG Xi KY Ding XL Su DF Chen WC You Y Shen 2004 p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions Carcinogenesis 25 2201 2206 10.1093/carcin/bgh229
30. K Mizokami Y Kakeji S Oda Y Maehara 2006 Relationship of hypoxia-inducible factor 1alpha and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer World J Surg Oncol 4 94 10.1186/1477-7819-4-94
31. C Bouchard K Thieke A Maier R Saffrich J Hanley-Hyde W Ansorge 1999 Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 EMBO J 18 5321 5333 10.1093/emboj/18.19.5321
32. BA Narayanan 2006 Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets Curr Cancer Drug Targets 6 711 727 10.2174/156800906779010218
33. H Yang Y Zhang R Zhao 2006 Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt Oncogene 25 4585 4594 10.1038/sj.onc.1209481
34. GK Anagnostopoulos D Stefanou E Arkoumani 2005 Bax and Bcl-2 protein expression in gastric precancerous lesions: immunohistochemical study J Gastroenterol Hepatol 20 1674 1678 10.1111/j.1440-1746.2005.04057.x
35. K Triantafyllou P Kitsanta DG Karamanolis C Kittas SD Ladas 2008 Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population Dig Liver Dis 40 39 45 10.1016/j.dld.2007.09.010